Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Technology Innovation Has the Potential to Improve the Future of Healthcare

Technologies such as analytics, cloud, mobile tools, open APIs, and apps are redesigning the healthcare system infrastructure. These innovative resources offer access to more patient data than has ever been available before, providing hospitals and providers with an unprecedented opportunity to improve the future of healthcare. Healthcare Innovation is Needed in a Number of Areas…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Technologies such as analytics, cloud, mobile tools, open APIs, and apps are redesigning the healthcare system infrastructure. These innovative resources offer access to more patient data than has ever been available before, providing hospitals and providers with an unprecedented opportunity to improve the future of healthcare.

Healthcare Innovation is Needed in a Number of Areas

According to 63% of 150 B2B healthcare information and technology marketers responding to an August 2018 Technology Innovation in Healthcare Survey by HIMSS Media, interoperability is the technology innovation most needed in healthcare. Clearly healthcare technology needs to work better from practice to practice. In addition, 52% stated that patient experience can be improved through technology, with nearly 50% wanting to see more progress in the area of electronic healthcare records (EHRs).

Improving Interoperability

HIMSS defines interoperability as the ability of different information technology systems and software applications to communicate, exchange data, and then utilize the information that has been exchanged. Data shared between clinicians, labs, hospitals, pharmacies, and patients, independent of the application or vendor, can generate huge gains in efficiency. More importantly, when interoperability is working at its best, the interchange of patient data among caregivers and other authorized parties from various EHR systems enables a safer, higher quality efficacy of healthcare delivery for individuals and communities both.

Using EHRs and Patient Portals to Improve the Patient Experience

EHRs (Electronic Health Records) are real-time, patient-centered records of an individual’s medical and treatment history. But EHRs have the potential to be so much more than simply an electronic version of a paper file. EHRs that can be accessed through a user-friendly patient portal have the potential to provide a much broader and more comprehensive view of the care a patient has received. EHRs can contain a patient’s medical history, diagnoses, medications, treatment plans, immunization dates, and allergies, as well as radiology images, and laboratory and test results. Adding the advanced analytical capabilities of evidence-based tools to leverage this vital information can assist in clinical decision-making, giving providers the powerful resources necessary to make informed decisions about a patient’s care, creating a healthier society overall.

Barriers to Technology Adoption

There are several factors affecting adoption of fully integrated EHR systems within U.S. hospitals and primary care practices. In addition to technical issues, such as system interoperability and standardization deficiencies, many users have concerns about privacy and confidentiality, a lack of health information data standards, and the number and transience of vendors in the marketplace. Further, in a time when budgets are tight, EHR products require a significant investment. And, of course, many individuals are simply resistant to change or possibly daunted by the learning curve associated with new technology adoption.

ChartLogic Has the Tools to power Healthcare Innovation

EHRs and interoperability offer numerous benefits for providers and patients alike. With initiatives to overcome challenges already gaining traction, advancements and adoption will become steadily universal. ChartLogic continues to improve and grow, staying current with technology trends to ensure improved patient care, office efficiency, and profitability for physician practices. For example, ChartLogic’s Connect Patient is a multifunction patient portal and communications platform that works with any device or browser. And Connect Patient integrates seamlessly with ChartLogic’s comprehensive ambulatory EHR suite that includes Electronic Medical RecordsPractice Management, and Billing Services.

To learn how ChartLogic is improving the future of healthcare, visit http://www.chartlogic.com/about/.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512